1. Stocks
  2. Aarti Pharmalabs Ltd.
  3. Swot
swot-logo

Aarti Pharmalabs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Aarti Pharmalabs Ltd. has 14 Strengths, 12 Weaknesses, 2 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Top Gainers

Volume Shockers

Stocks near 52 Week High with Significant Volumes

Promoter decreasing their shareholding

Promoters increased pledged shares QoQ

Companies with growing costs YoY for long term projects

Decline in Quarterly Net Profit (YoY)

Declining Net Cash Flow : Companies not able to generate net cash

Fall in Quarterly Revenue and Net Profit (YoY)

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

High promoter stock pledges

Highest increase in pledges by promoters

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)